Recently, the 5-HT1A receptor has been implicated in both susceptibility to depression and as a factor moderating the response to SSRI treatment (Blier, 2010; Richardson-Jones et al., 2010, 2011; Donaldson et al., 2013). Here, HTR1A is linked to depressive disorder.